MENU
+Compare
AIM
Stock ticker: ASE
AS OF
Apr 3, 03:18 PM (EDT)
Price
$0.12
Change
-$0.00 (-0.00%)
Capitalization
8.32M

AIM AIM ImmunoTech Forecast, Technical & Fundamental Analysis

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases... Show more

AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AIM with price predictions
Apr 02, 2025

AIM's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for AIM turned positive on February 27, 2025. Looking at past instances where AIM's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AIM's RSI Indicator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AIM advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AIM as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AIM broke above its upper Bollinger Band on March 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AIM entered a downward trend on March 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.888) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (39.841) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AIM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AIM is expected to report earnings to fall 10.00% to -9 cents per share on May 15

AIM ImmunoTech AIM Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.09
Q1'24
Est.
$-0.12
The last earnings report on March 27 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 156.80K shares outstanding, the current market capitalization sits at 8.32M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVA3.100.16
+5.44%
Inventiva SA
CNO42.370.39
+0.93%
CNO Financial Group
MAA168.000.52
+0.31%
Mid-America Apartment Communities
CARV1.43N/A
-0.35%
Carver Bancorp
DX12.81-0.18
-1.39%
Dynex Capital

AIM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AIM has been loosely correlated with HOTH. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if AIM jumps, then HOTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIM
1D Price
Change %
AIM100%
-3.20%
HOTH - AIM
33%
Loosely correlated
+0.38%
VRCA - AIM
24%
Poorly correlated
-0.86%
PASG - AIM
24%
Poorly correlated
+1.30%
EDSA - AIM
24%
Poorly correlated
+5.60%
GERN - AIM
24%
Poorly correlated
+7.43%
More